Endothelin Receptor Antagonist class drugs
2 results
Ambrisentan (ambrisentan)
(Ambrisentan)Zydus Lifesciences Limited
Filspari (sparsentan)
(sparsentan)Travere Therapeutics, Inc.
Usage: FILSPARI is indicated for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression.